Adaptimmune Therapeutics PLC 4
4 · Adaptimmune Therapeutics PLC · Filed Aug 12, 2016
Insider Transaction Report
Form 4
Knowles Jonathan Kenneth Charles
Director
Transactions
- Award
Option to purchase Ordinary Shares
2016-08-11+217,222→ 217,222 totalExercise: $1.27From: 2017-08-11Exp: 2026-08-11→ Ordinary Shares (217,222 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.97 based on the closing midpoint exchange rate for the U.S. dollar on the day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.